A detailed history of Smithfield Trust CO transactions in Embecta Corp. stock. As of the latest transaction made, Smithfield Trust CO holds 42 shares of EMBC stock, worth $849. This represents 0.0% of its overall portfolio holdings.

Number of Shares
42
Previous 42 -0.0%
Holding current value
$849
Previous $1,000 -0.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$10.13 - $14.6 $374 - $540
-37 Reduced 46.84%
42 $1,000
Q1 2024

May 07, 2024

SELL
$12.35 - $19.33 $135 - $212
-11 Reduced 12.22%
79 $1,000
Q2 2023

Aug 08, 2023

SELL
$21.6 - $30.69 $1,296 - $1,841
-60 Reduced 40.0%
90 $1,000
Q1 2023

May 11, 2023

SELL
$23.07 - $32.77 $230 - $327
-10 Reduced 6.25%
150 $3,000
Q4 2022

Feb 13, 2023

SELL
$25.29 - $35.48 $1,289 - $1,809
-51 Reduced 24.17%
160 $3,000
Q3 2022

Nov 14, 2022

BUY
$24.0 - $33.42 $5,064 - $7,051
211 New
211 $3,000

Others Institutions Holding EMBC

About Embecta Corp.


  • Ticker EMBC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 57,836,500
  • Market Cap $1.17B
  • Description
  • Embecta Corp., a medical device company, focuses on the provision of various solutions to enhance the health and wellbeing of people living with diabetes. Its products include pen needles, syringes, and safety devices, as well as digital applications to assist people with managing their diabetes. The company primarily sells its products to whole...
More about EMBC
Track This Portfolio

Track Smithfield Trust CO Portfolio

Follow Smithfield Trust CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Smithfield Trust CO, based on Form 13F filings with the SEC.

News

Stay updated on Smithfield Trust CO with notifications on news.